{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T21:22:17Z","timestamp":1787865737802,"version":"build-2784847793"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24\\u202FK11039"],"award-info":[{"award-number":["24\\u202FK11039"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microvascular Research"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.mvr.2026.104962","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T15:50:42Z","timestamp":1780069842000},"page":"104962","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Vasculitis-associated aberrant apolipoprotein A2\u00a0=\u00a0VAP2 and SDF-1\u03b1 in Kawasaki disease patients with coronary artery lesion"],"prefix":"10.1016","volume":"167","author":[{"given":"Ryota","family":"EBATA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"SUZUKI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuko","family":"UNO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"KAMEOKA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitomo","family":"HAMANO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyu","family":"ITO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"MURATA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruna","family":"ASANO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"MATSUSHITA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"FURUTA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"MIKI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromichi","family":"HAMADA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"SUZUKI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mvr.2026.104962_bb0005","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1097\/00006454-200211000-00002","article-title":"Commentary: translation of Dr. Tomisaku Kawasaki\u2019s original report of fifty patients in 1967","volume":"21","author":"Burns","year":"2002","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.mvr.2026.104962_bb0010","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.jacc.2009.04.102","article-title":"When children with Kawasaki disease grow up: Myocardial and vascular complications in adulthood","volume":"54","author":"Gordon","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.mvr.2026.104962_bb0015","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.cyto.2012.08.006","article-title":"Inflammatory cytokine profiles during Cyclosporin treatment for immunoglobulin-resistant Kawasaki disease","volume":"60","author":"Hamada","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.mvr.2026.104962_bb0020","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1284","article-title":"The up-to-date pathophysiology of Kawasaki disease","volume":"10","author":"Hara","year":"2021","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.mvr.2026.104962_bb0025","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s12265-019-09908-y","article-title":"Oxidised Low-Density Lipoprotein and Its Receptor-Mediated Endothelial Dysfunction Are Associated with Coronary Artery Lesions in Kawasaki Disease","volume":"13","author":"He","year":"2020","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.mvr.2026.104962_bb0030","doi-asserted-by":"crossref","first-page":"469","DOI":"10.5551\/jat.ED150","article-title":"Apolipoprotein A2 Isoforms: New Insight into the Risk of Myocardial Infarction","volume":"28","author":"Hisamatsu","year":"2021","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.mvr.2026.104962_bb0035","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1093\/ndt\/gfh275","article-title":"Neutrophil contribution to the crescentic glomerulonephritis in SCG\/Kj mice","volume":"19","author":"Ishida-Okawara","year":"2004","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.mvr.2026.104962_bb0040","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12969-022-00783-7","article-title":"Beneficial effects of anti-apolipoprotein A-2 on an animal model for coronary arteritis in Kawasaki disease","volume":"20","author":"Ito","year":"2022","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"10.1016\/j.mvr.2026.104962_bb0045","first-page":"384","article-title":"Determination of myeloperoxidase-induced apoAI-apoAII heterodimers in high-density lipoprotein","volume":"42","author":"Kameda","year":"2012","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.mvr.2026.104962_bb0050","doi-asserted-by":"crossref","first-page":"592594","DOI":"10.1155\/2015\/592594","article-title":"Effects of myeloperoxidase-induced oxidation on antiatherogenic functions of high-density lipoprotein","volume":"2015","author":"Kameda","year":"2015","journal-title":"J. Lipids"},{"key":"10.1016\/j.mvr.2026.104962_bb0055","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2147\/DDDT.S188651","article-title":"Efficacy of a recombinant single-chain fragment variable region, VasSF, as a new drug for vasculitis","volume":"13","author":"Kameoka","year":"2019","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.mvr.2026.104962_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156280","article-title":"Clinical significance of serum cytokine profiles for differentiating between Kawasaki disease and its mimickers","volume":"169","author":"Kaneko","year":"2023","journal-title":"Cytokine"},{"key":"10.1016\/j.mvr.2026.104962_bb0065","first-page":"178","article-title":"Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children [in Japanse]","volume":"16","author":"Kawasaki","year":"1967","journal-title":"Arerugi"},{"key":"10.1016\/j.mvr.2026.104962_bb0070","doi-asserted-by":"crossref","first-page":"20638","DOI":"10.1038\/s41598-021-98253-9","article-title":"Identification of serum prognostic biomarkers of severe COVID-19 using a quantitative proteomic approach","volume":"11","author":"Kimura","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mvr.2026.104962_bb0075","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/ped.14326","article-title":"Revision of diagnostic guidelines for Kawasaki disease (6th revised edition)","volume":"62","author":"Kobayashi","year":"2020","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.mvr.2026.104962_bb0080","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/cei\/uxad140","article-title":"Enhanced efficacy of the novel recombinant clone VasSF in a mouse model of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"216","author":"Koura","year":"2024","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.mvr.2026.104962_bb0085","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.freeradbiomed.2013.10.007","article-title":"Comparative reactivity of the myeloperoxidase-derived oxidants hypochlorous acid and hypothiocyanous acid with human coronary artery endothelial cells","volume":"65","author":"Lloyd","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.mvr.2026.104962_bb0090","doi-asserted-by":"crossref","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.mvr.2026.104962_bb0095","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16006","article-title":"Inflammation biomarkers in acute ischemic stroke according to different etiologies","volume":"31","author":"Meisinger","year":"2024","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.mvr.2026.104962_bb0100","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1440-1797.1997.tb00237.x","article-title":"Increased release of myeloperoxidase in vitro from neutrophils of patients with myeloperoxidase-specific anti-neutrophil cytoplasmic antibody (MPO-ANCA) related glomerulonephritis","volume":"3","author":"Minoshima","year":"1997","journal-title":"Nephrology"},{"key":"10.1016\/j.mvr.2026.104962_bb0105","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1161\/01.CIR.0000151311.38708.29","article-title":"Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease","volume":"111","author":"Mitani","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.mvr.2026.104962_bb0110","first-page":"41","article-title":"Guidelines for medical treatment of acute Kawasaki disease (2020 revised version)","volume":"5","author":"Miura","year":"2021","journal-title":"J. Pediatr. Cardiol. Card. Surg."},{"key":"10.1016\/j.mvr.2026.104962_bb0115","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM198608073150601","article-title":"The treatment of Kawasaki syndrome with intravenous gamma globulin","volume":"315","author":"Newburger","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mvr.2026.104962_bb0120","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1161\/01.CIR.84.2.625","article-title":"Altered lipid profile after Kawasaki syndrome","volume":"84","author":"Newburger","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.mvr.2026.104962_bb0125","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/j.jacc.2015.12.073","article-title":"Kawasaki Disease","volume":"67","author":"Newburger","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.mvr.2026.104962_bb0130","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1253\/jcj.46.1039","article-title":"Serum HDL-cholesterol and lipoprotein fraction in Kawasaki disease (acute mucocutaneous lymph node syndrome)","volume":"46","author":"Okada","year":"1982","journal-title":"Jpn. Circ. J."},{"key":"10.1016\/j.mvr.2026.104962_bb0135","series-title":"Progress in Clinical and Biological Research 250: Kawasaki Disease","first-page":"557","article-title":"Enzyme release and O2-production of neutrophis and vascular lesions in gammma globulin therapy of Kawasaki disease","author":"Okazaki","year":"1987"},{"key":"10.1016\/j.mvr.2026.104962_bb0140","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jinf.2010.11.012","article-title":"Interleukin 12 and myeloperoxidase (MPO) in Vietnamese children with acute respiratory distress syndrome due to Avian influenza (H5N1) infection","volume":"62","author":"Phung","year":"2011","journal-title":"J. Infect."},{"key":"10.1016\/j.mvr.2026.104962_bb0145","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/ATVBAHA.112.300921","article-title":"Apolipoprotein A-II: still second fiddle in high-density lipoprotein metabolism?","volume":"33","author":"Remaley","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.mvr.2026.104962_bb0150","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1089\/ars.2012.4660","article-title":"Does oxidative stress play a critical role in cardiovascular complications of Kawasaki disease?","volume":"17","author":"Straface","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.mvr.2026.104962_bb0155","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s12350-022-03041-1","article-title":"Ongoing vascular inflammation evaluated by (18)F-fluorodeoxyglucose positron emission tomography in patients long after Kawasaki disease","volume":"30","author":"Suda","year":"2023","journal-title":"J. Nucl. Cardiol."},{"key":"10.1016\/j.mvr.2026.104962_bb0160","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/ja.2013.132","article-title":"Leucomycin A3, a 16-membered macrolide antibiotic, inhibits influenza A virus infection and disease progression","volume":"67","author":"Sugamata","year":"2014","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.mvr.2026.104962_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2024.104720","article-title":"Dynamics of scFv-targeted VAP2 correlating with IL-16, MIF and IL-1Ra in ANCA-associated vasculitis","volume":"156","author":"Suzuki","year":"2024","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.mvr.2026.104962_bb0170","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/ATVBAHA.112.300445","article-title":"Human apolipoprotein A-II protects against diet-induced atherosclerosis in transgenic rabbits","volume":"33","author":"Wang","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.mvr.2026.104962_bb0175","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1126\/science.8332912","article-title":"Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II","volume":"261","author":"Warden","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.mvr.2026.104962_bb0180","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.atherosclerosis.2007.11.017","article-title":"The apolipoprotein AII rs5082 variant is associated with reduced risk of coronary artery disease in an Australian male population","volume":"199","author":"Xiao","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.mvr.2026.104962_bb0185","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12872-021-02059-6","article-title":"Reduced plasma level of basic fibroblast growth factor is associated with incomplete device endothelialization at six months following left atrial appendage closure","volume":"21","author":"Xu","year":"2021","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.mvr.2026.104962_bb0190","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.4049\/jimmunol.1002924","article-title":"Apolipoprotein A-II suppressed concanavalin A-induced hepatitis via the inhibition of CD4 T cell function","volume":"186","author":"Yamashita","year":"2011","journal-title":"J. Immunol."}],"container-title":["Microvascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026286226000622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026286226000622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:55:43Z","timestamp":1787864143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026286226000622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":38,"alternative-id":["S0026286226000622"],"URL":"https:\/\/doi.org\/10.1016\/j.mvr.2026.104962","relation":{},"ISSN":["0026-2862"],"issn-type":[{"value":"0026-2862","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vasculitis-associated aberrant apolipoprotein A2\u00a0=\u00a0VAP2 and SDF-1\u03b1 in Kawasaki disease patients with coronary artery lesion","name":"articletitle","label":"Article Title"},{"value":"Microvascular Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mvr.2026.104962","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104962"}}